JSF-4898
JSF-4898 is an orally bioactive inhibitor of Mycobacterium tuberculosis MenG enzyme. It exhibits a minimum inhibitory concentration (MIC) of 0.78 μM against Mycobacterium tuberculosis H37Rv. Additionally, JSF-4898 enhances the efficacy of rifampicin in a subacute infection model of Mycobacterium tuberculosis in mice.
Product Specifications
Field of Research
Infectious Disease & Virology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
39117116 3x 1.0 µg
RGD1310852 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
OR1073897-01 5 mg
N- (Furan-2-ylmethyl) -6-hydroxy-N- (thiophen-2-ylmethyl) nicotinamide
Sign In for Pricing
View Details OR1073897-02 10 mg
N- (Furan-2-ylmethyl) -6-hydroxy-N- (thiophen-2-ylmethyl) nicotinamide
Sign In for Pricing
View Details OR1073897-03 25 mg
N- (Furan-2-ylmethyl) -6-hydroxy-N- (thiophen-2-ylmethyl) nicotinamide
Sign In for Pricing
View Details OR1073897-04 50 mg
N- (Furan-2-ylmethyl) -6-hydroxy-N- (thiophen-2-ylmethyl) nicotinamide
Sign In for Pricing
View Details OR1073897-05 100 mg
N- (Furan-2-ylmethyl) -6-hydroxy-N- (thiophen-2-ylmethyl) nicotinamide
Sign In for Pricing
View Details